Skip to main content
SpringerLink
Log in

Response to ‘A Spoonful of Regulation Helps the Medicine Go Down’

  • Medicine Regulation
  • Published:
Social Theory & Health Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Abraham J, Bardelay D, Kopp C, Kleinke JD, Bennion E (2002). Education and debate: making regulation responsive to commercial interests: streamlining drug industry watchdogs. British Medical Journal 325: 1164–1169.

    Article  Google Scholar 

  • Anderson S (2005). Drug regulation and the welfare state: government, the pharmaceutical industry and the health professions in Great Britain 1940—1980. In: Berridge V, Loughlin K (eds). Medicine, the Market and the Mass Media.. Routledge: London.

    Google Scholar 

  • Busfield J (2006). Pills, power, people: sociological understandings of the pharmaceutical industry. Sociology 40: 297–314.

    Article  Google Scholar 

  • Cohen JP, Paquette C, Cairns CP (2005). Switching prescription drugs to over the counter. British Medical Journal 330: 39–41.

    Article  Google Scholar 

  • Glynn A (2006). Capitalism Unleashed. Oxford University Press: Oxford.

    Google Scholar 

  • Higgs P (1998). Risk, governmentality and the reconceptualisation of citizenship. In: Scambler G, Higgs P (eds). Modernity, Medicine and Health. Routledge: London.

    Google Scholar 

  • Law MR, Wald NJ (2002). Risk factor thresholds: their existence under scrutiny. British Medical Journal 324: 1570–1576.

    Article  Google Scholar 

  • Moncrieff J . Neoliberalism and psychiatry: a marriage of convenience. In: Timimi S, Cohen CI (eds). Liberatory Psychiatry, Cambridge University Press: in press.

  • Moynihan R, Heath I, Henry D (2002). Selling sickness: the pharmaceutical industry and disease mongering. British Medical Journal 324: 886–891.

    Article  Google Scholar 

  • Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, Nakaya N, Nishimoto S, Muranaka M, Yamamoto A, Mizuno K, Ohashi Y (2006). Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet 368: 1155–1163.

    Article  Google Scholar 

  • National Institute for Clinical Excellence (2006). Statins for the prevention of cardiovascular events in patients at increased risk of developing cardiovascular disease or those with established cardiovascular disease. National Institute for Clinical Excellence: London.

  • Pignone M, Phillips C, Mulrow C (2000). Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials. British Medical Journal 321: 983–986.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Mental Health Sciences, University College, London, UK

    Joanna Moncrieff

Authors
  1. Joanna Moncrieff
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moncrieff, J. Response to ‘A Spoonful of Regulation Helps the Medicine Go Down’. Soc Theory Health 5, 176–179 (2007). https://doi.org/10.1057/palgrave.sth.8700099

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1057/palgrave.sth.8700099

Search

Navigation